April 24, 2007 08:39 ET

CN donates $250,000 to the Atlantic Cancer Research Institute's Discoveries campaign to fight against cancer

MONCTON, NEW BRUNSWICK--(CCNMatthews - April 24, 2007) - CN announced today that it has donated $250,000 to the Atlantic Cancer Research Institute (ACRI), the largest centre in Atlantic Canada dedicated to cancer research. This contribution will help ACRI purchase leading-edge technology that is increasingly important in the development of new diagnoses and targeted treatments. Cancer is the principal cause of premature death in Canada and the number of new cancer cases will increase by approximately 60 per cent over the next 20 years due to population growth and aging.

The objective of the Discoveries campaign is to raise $8.5 million over the next five years. The money raised will enable the Institute to finance projects in genomics and proteomics research, fields that help decode all genetic information and help researchers understand the uncontrolled growth of abnormal cells, the common trait of all cancers. The funds will also help ACRI continue to recruit some of the best research professionals.

CN president and chief executive officer E. Hunter Harrison said: "CN has strong ties to Atlantic Canada and its communities. Building stronger communities where we operate and where our employees live and work is important to CN. We know that supporting cancer research here in Moncton is also supporting the patients who benefit from the unique expertise of this centre of excellence."

Denis Losier, chairman of the Discoveries campaign, said: "This is a pivotal time in the evolution of cancer research. Working together, we can all make a difference in eradicating this disease. Through this partnership with CN, ACRI can continue to be at the forefront of research in genomics and biomedical sciences to seek out the genetic origins of cancer, develop new diagnostic tools and therapies, and ultimately help find a cure for the disease."

Since it was established in 1998, the Atlantic Cancer Research Institute has been an active participant in the global cancer research effort. Among its achievements, ACRI has filed two patents in collaboration with the National Research Council of Canada for molecular methods for diagnosing prostate and colon cancer.

As a leading North American freight transportation company, CN is committed to help build safer, stronger communities in the cities and towns through which its trains travel.

CN - Canadian National Railway Company - spans Canada and mid-America, from the Atlantic and Pacific oceans to the Gulf of Mexico, serving the ports of Vancouver, Prince Rupert, B.C., Montreal, Halifax, New Orleans, and Mobile, Ala., and the key cities of Toronto, Buffalo, Chicago, Detroit, Duluth, Minn./Superior, Wis., Green Bay, Wis., Minneapolis/St. Paul, Memphis, St. Louis, and Jackson, Miss., with connections to all points in North America.

Contact Information

  • CN
    Julie Senecal (Media)
    (514) 399-4048
    Atlantic Cancer Research Institute
    Francoise Roy (Media)
    (506) 862-4221